It's to a large extent national security. In addition, you can't continue to pay 13, 14 times more than other countries. And I think you're going to have security. Collectively, they will invest over $150 billion to build up domestic pharmaceutical manufacturing in America. They're going to be because of tariffs they're coming in and I think because of the love of our country. It may be because of the November 5 election, but because of tariffs, they're going to be coming in. (19:49–19:59)
CLAIM
Asserts that pharmaceutical companies will invest over $150 billion in U.S. manufacturing.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
